Oncology Pipeline Director

Uniting science, technology and talent to get ahead of disease together GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas – respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.

People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can perform and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.

GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our positive impact on people’s health.

Our strategy is to prevent and treat disease with specialty medicines, vaccines and general medicines.

We combine the science of the immune system with advanced technologies, enhanced by targeted business development and world-class partnerships, to develop new medicines and vaccines that can help transform people’s lives.

Position Summary

The Oncology Pipeline Director is responsible for representing the Canadian commercial perspective across the lifecycle of key novel oncology assets or indications including ensuring development, commercialization strategy, and launch planning are optimized for the Canadian market. This role serves as the primary Canadian commercial leader interfacing with the global asset team and regional asset teams for all Oncology assets or indications, providing strategic guidance and input on Canadian needs for commercial readiness to maximize asset / indication value.

The Director will work cross-functionally with Medical Affairs, Market Access, Regulatory and Business Intelligence in Canada to shape the development path and commercialization strategy for the assets / indications including prioritization, resource and investment allocation / timing and business case / P&L development. The role requires deep expertise in Canadian oncology market dynamics, competitive intelligence, payer landscape, and launch excellence, ensuring the Canadian perspective is considered and localized from global or regional strategy.

Responsibilities

• Canada Oncology Asset / Indication Strategy Leadership:
  • Serve as the Canadian commercial lead for all oncology assets / indications on global and regional teams, ensuring the Canadian perspective is considered in development and commercialization decisions.
  • Shape Canadian positioning strategy, value proposition, and differentiation relative to current and emerging competitors.
  • Member of the Oncology Leadership Team
  • Translate Canadian market insights into actionable strategy for local and global/regional teams as needed.
  • Partner with local Medical and Clinical teams to ensure understanding of local drivers and barriers of success of clinical trial sites in Canada and implications for potential commercial success or needs.
  • Identify opportunities to optimize label potential and market access positioning.
• Canada Market Intelligence & Competitive Strategy:
  • Lead the cross-functional team for Canada for market landscape assessments, including:
    • Disease epidemiology
    • Treatment paradigms
    • Competitive intelligence
  • Monitor evolving competitive pipelines across tumor types, translating insights into strategic implications.
• Forecasting & Business Case Development:
  • Collaborate with Business Intelligence to develop robust Canadian forecasts and scenario planning.
  • Lead assessment of commercial opportunity, pricing potential, and market uptake dynamics.
  • Provide strategic input into investment decisions and lifecycle planning.
• Cross-Functional Leadership:
  • Serve as a key integrator across:
    • Oncology Commercial Leadership
    • Medical Affairs
    • Market Access
    • Regulatory
    • Business Intelligence
  • Drive alignment and integrated strategic plan development across stakeholders to ensure timely and strategic decision making.

Leadership Competencies

• Strategic thinking and ability to translate insights into actionable strategy
• Enterprise leadership across complex global matrix organizations
• Strong commercial acumen in oncology markets
• Influencing without authority
• Data-driven decision making

Basic Qualifications

• Bachelor’s degree in business, life sciences, healthcare, or related field.
• 10+ years of experience in the biopharmaceutical industry with 3-5+ years' experience in oncology
• Strong planning & organizational skills, and the ability to work efficiently and effectively in a dynamic environment
• Strong independent researching skills using a variety of modes from scientific publication, reputable internet and/or AI-supporting researching experience
• Ability to influence without authority and drive towards a goal across multiple stakeholders
• Effective time management skills. Ability to effectively manage multiple priorities and responsibilities of increasing scope and complexity
• Reliability, independence and punctuality (high level of professionalism)
• Excellent verbal and written communication skills
• Self-motivated, accountable, passionate, committed, invested in the business
• Strong interpersonal skills
• Ability to identify problems early and seek innovative solutions
• Proficiency in Microsoft Office (Excel, PowerPoint & Word)

Preferred Qualifications

• Advanced scientific degree (MD, MSc or PhD) and/or MBA
• Specific training in marketing, forecasting/analytics, management consulting and leading teams
• Bilingualism (English / French)
• Experience supporting late-stage development, launch planning, or commercialization of oncology therapies

Working Pattern

This role is hybrid. You will be expected to be on‑site in our Mississauga office 2-3 days per week for key meetings and team activities and work remotely as agreed with your manager.

What we offer

You will have the chance to shape programs that could change patient outcomes. You will work across diverse teams and grow your leadership and scientific expertise. We welcome applicants who bring curiosity, humility, and a commitment to inclusion.

Why GSK?

GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law. GSK is committed to accommodating persons with disabilities. If you need accommodation at any stage of the application process or want more information on our accommodation policies, please contact us at canada-recruitment@gsk.com.

#J-18808-Ljbffr